Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide-1 Receptor Agonists”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnrolling By InvitationNCT06581120
What this trial is testing

GLP_1 RA Ultrasound Study

Who this might be right for
Glucagon Like Peptide-1 (GLP-1Delayed Gastric EmptyingRisk of Aspiration+2 more
Children's Hospital Medical Center, Cincinnati 100
Not applicableLooking for participantsNCT07484061
What this trial is testing

Efficacy and Safety of a Drinkable Nutraceutical for Hair Loss in Patients Using GLP-1/GIP Receptor Agonists

Who this might be right for
Telogen Effluvium
Olistic Research Labs S.L. 40
Early research (Phase 1)Study completedNCT06634927
What this trial is testing

Pharmacokinetic Similarity, Safety, and Immunogenicity of Semaglutide Injection and Ozempic ® Injection in Healthy Subjects.

Who this might be right for
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 68
Not applicableStudy completedNCT03010683
What this trial is testing

Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus

Who this might be right for
Type 2 Diabetes MellitusCoronary Artery Disease
University of Athens 60
Not applicableLooking for participantsNCT07653412
What this trial is testing

Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.

Who this might be right for
Obesity (Disorder)Anti-obesity AgentsPrecision Medicine
National and Kapodistrian University of Athens 220
Not applicableActive Not RecruitingNCT05333003
What this trial is testing

Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity

Who this might be right for
Schizophrenia Spectrum Disorders
Centre for Addiction and Mental Health 92
Testing effectiveness (Phase 2)Study completedNCT06481085
What this trial is testing

To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 324
Not applicableLooking for participantsNCT07224880
What this trial is testing

Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists

Who this might be right for
glp1 AgonistGene ExpressionSkin Laxity
Cytrellis Biosystems, Inc. 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04019197
What this trial is testing

Effects of Semaglutide in HIV-Associated Lipohypertrophy

Who this might be right for
HIV/AIDSLipohypertrophyObesity
Case Western Reserve University 108
Not applicableLooking for participantsNCT07244458
What this trial is testing

Dietary Peanuts and Nutrition-Related Outcomes

Who this might be right for
Dietary ChangeObesity & OverweightFood Acceptance
Ian J. Neeland, MD 64
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07642635
What this trial is testing

Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy (DMD)
Vanderbilt University Medical Center 30
Not applicableStudy completedNCT07455630
What this trial is testing

Cardiac Function and Biomarkers in Patients With Obesity and Overweight

Who this might be right for
Obesity & Overweight
TecSalud Investigación Clínica 30
Not applicableLooking for participantsNCT06839248
What this trial is testing

Effect of Fasting Recommendations Among Patients Using GLP-1 Receptor Agonists

Who this might be right for
Residual Gastric ContentsPulmonary Aspiration of Gastric Contents
St Vincent's Hospital Melbourne 154
Not applicableStudy completedNCT04184947
What this trial is testing

Cardiovascular Outcomes SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists

Who this might be right for
Type 2 Diabetes
University of Padova 10,000
Not applicableNot Yet RecruitingNCT07783113
What this trial is testing

Dietary Supplement for Telogen Effluvium Associated With GLP-1 Receptor Agonist Use

Who this might be right for
Alopecia
Farmoquimica S.A. 48
Large-scale testing (Phase 3)Looking for participantsNCT07575399
What this trial is testing

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Who this might be right for
Obesity or Overweight
Amgen 300
Not applicableLooking for participantsNCT07736963
What this trial is testing

Discontinuation Recommendations for GLP-1 Receptor Agonists Prior to Colonoscopy

Who this might be right for
GLP-1
Fu Jen Catholic University Hospital 240
Post-approval studies (Phase 4)Not Yet RecruitingNCT07073053
What this trial is testing

The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms

Who this might be right for
Glucagon-Like Peptide-1 Receptor AgonistsType 2 DiabetesCoronary Arterial Disease (CAD)
Taipei Veterans General Hospital, Taiwan 60
Not applicableNot Yet RecruitingNCT07668765
What this trial is testing

GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid Obesity

Who this might be right for
Morbid ObesityAnorectal DiseasesDrug-Related Side Effects and Adverse Reactions+2 more
Gazi University 100
Post-approval studies (Phase 4)Looking for participantsNCT07017270
What this trial is testing

Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis

Who this might be right for
Kidney Disease, ChronicDiabetesDialysis+1 more
Unity Health Toronto 100
Next Page